JournalsHub
.online
Find My Journal
SB

Sandro Bruno

Novartis (Switzerland) CH

ORCID 0009-0008-7182-4492
16
Publications
348
Citations
5
H-Index
2
i10-Index
0.45
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Interleukin-26 potentiates type 2 skin inflammation in presence of interleukin-1β.

K. Bier, Z. Senajova, F. Henrion, Yichen Wang, S. Bruno - Journal of Investigative Dermatology, 2024
Cited by 2 Semantic Scholar

225 Interleukin-1β licenses interleukin-26 to potentiate type 2 skin inflammation OA

K. Bier, Z. Senajova, F. Henrion, Y. Wang, S. Bruno - Journal of Investigative Dermatology, 2023
Cited by 0 Semantic Scholar

Research Topics

Dermatology and Skin Diseases (7) Psoriasis: Treatment and Pathogenesis (6) Asthma and respiratory diseases (3) BRCA gene mutations in cancer (3) Allergic Rhinitis and Sensitization (3)

Affiliations

Novartis (Switzerland)
CH 2026 - 2021
Novartis Institutes for BioMedical Research
2023 - 2021
Friedrich Miescher Institute
CH 2021 - 2021

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now